Week of August 8, 2023 | Vol. 12, Issue 31

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Biostorage Services Market Insight

July 2023

Market Insight Capital Markets Update

October 2022

Pharma Sector Snapshot 1H 2022

August 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

US Food and Drug Administration (FDA) purchase the LiFT system from DIANT® Pharma INC.

PR Newswire - Jul 31, 2023

Santhera fully divests rare eye disease drug Raxone to Chiesi

Pharmaceutical Technology - Jul 31, 2023

Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva

PR Newswire - Jul 31, 2023

BioNTech acquires tech company InstaDeep for $549m

Pharmaceutical Technology - Aug 1, 2023

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for the Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

Northway Biotech - Aug 1, 2023

Scleroderma clinical trial initiative snags Sanofi as first partner to accelerate research

Fierce Biotech - Aug 1, 2023

Sitero acquires eClinical technology from Clario to boost services

Fierce Biotech - Aug 2, 2023

Sygnature Discovery Acquires NuChem Sciences

Conract Pharma - Aug 2, 2023

Deal focus: Biogen’s gambit to boost neurology portfolio with Reata acquisition

Pharmaceutical Technology - Aug 3, 2023

MindMed Announces Exclusive License Agreement With Catalent for Its Patented Zydis® Fast-Dissolve Technology for Use with MM-120

MindMed - Aug 3, 2023

Kindeva Drug Delivery Receives £33M U.K. Government Grant

Contract Pharma - Aug 3, 2023

Kohlberg signs a definitive agreement to acquire majority stake in Worldwide Clinical Trials

Business Wire - Aug 7, 2023

TANNER NEWS

Early access programs: how real-world data capture helps regulatory approval

While clinical trials can prove that a medical product is safe and effective in a controlled environment, the vital data for how a new medicine will perform in the real world is often lacking. Learn more about the connection between real-world data capture and early access programs, and the role this plays in the approval of life-improving medicines.